The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (30)

• Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? via openalex
• Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
• Delayed oral estradiol combined with leuprolide increases endometriosis-related pain. via openalex
• Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis via openalex
• Endometriosis: Treatment Strategies via openalex
• Evaluation and management of women with endometriosis via openalex
• Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis via openalex
• Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
• Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery via openalex
• Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex
• Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
• One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial via openalex
• Optimizing Gonadotropin-Releasing Hormone Agonist Therapy in Women with Endometriosis via openalex
• Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain via openalex
• Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial via openalex
• Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
• Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. via openalex
• W6717470657 via openalex
• W201040832 via openalex
• W1512318310 via openalex
• W2009881284 via openalex
• W2018099070 via openalex
• W2028655493 via openalex
• W2031570803 via openalex
• W2061300003 via openalex
• W2092407540 via openalex
• W2114724335 via openalex
• W2134137902 via openalex
• W2157890226 via openalex
• W6607058909 via openalex

Cited by (20)

• Agonists of gonadotropin-releasing-hormone and add-back-therapy 2023
• A mouse model of endometriosis that displays vaginal, colon, cutaneous, and bladder sensory comorbidities 2021
• Pathogenesis of pelvic pain syndrome associated with endometriosis in patients resistant to surgical treatment  2020
• Endometrial thickness in the evaluation of clinical response to medical treatment for deep infiltrating endometriosis: a retrospective study 2020
• Laparoscopic Surgery Combined with GnRH Agonist in Endometriosis 2019
• Curative effect of 1.88‐mg and 3.75‐mg gonadotrophin‐releasing hormone agonist on stage III–IV endometriosis: Randomized controlled study 2017
• Pharmacologic treatment of the ovarian endometrioma 2016
• Low-dose add-back therapy during postoperative GnRH agonist treatment 2016
• Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial 2015
• Minimising menopausal side effects whilst treating endometriosis and fibroids 2015
• Modern view on endometriomas 2015
• Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone 2015
• The Place of Gonadotropin-Releasing Hormone Agonists in the Management of Endometriosis 2014
• Systematic review of endometriosis pain assessment: how to choose a scale? 2014
• Molecular Pathology and Therapy of Endometriosis: Revisited 2013
• Oral continuous combined 0.5 mg estradiol valerate and 5 mg dydrogesterone as daily add-back therapy during post-operative GnRH agonist treatment for endometriosis in Chinese women. 2013
• The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with estrogen-progestogen add-back therapy in endometriosis patients of reproductive age. 2013
• Endometriosis vesical aislada recidivante con repercusión renal 2012
• Hormonal strategy for the primary or secondary treatment of endometriosis 2012
• Quality of life according to add-back therapy during GnRH agonist treatment in endometriosis patients 2012

Source provenance

europepmc

last seen: 2026-06-04T01:30:01.192114+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:17:00.782903+00:00